-
1
-
-
0031783727
-
Treatment of acute renal failure
-
Star RA: Treatment of acute renal failure. Kidney Int 1998; 54:1817-1831
-
(1998)
Kidney Int
, vol.54
, pp. 1817-1831
-
-
Star, R.A.1
-
2
-
-
0034222937
-
Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial
-
Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356:26-30
-
(2000)
Lancet
, vol.356
, pp. 26-30
-
-
Ronco, C.1
Bellomo, R.2
Homel, P.3
-
3
-
-
0027946293
-
Effect of the dialysis membrane in the treatment of patients with acute renal failure
-
Hakim RM, Wingard RL, Parker RA: Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331:1338-1342
-
(1994)
N Engl J Med
, vol.331
, pp. 1338-1342
-
-
Hakim, R.M.1
Wingard, R.L.2
Parker, R.A.3
-
4
-
-
0012469306
-
Inflammatory mediators of renal ischemic reperfusion injury
-
Molitoris W, Finn W, Eds. Philadelphia, WB Saunders
-
Rabb H, Star R: Inflammatory mediators of renal ischemic reperfusion injury. In: Molitoris W, Finn W, Eds. Acute Renal Failure: A Companion to Brenner and Rector's The Kidney. Philadelphia, WB Saunders, 2001
-
(2001)
Acute Renal Failure: A Companion to Brenner and Rector's the Kidney
-
-
Rabb, H.1
Star, R.2
-
5
-
-
0032991434
-
Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability
-
Kramer A, Postler G, Salhab K, et al: Renal ischemia/reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 1999; 55:2362-2367
-
(1999)
Kidney Int
, vol.55
, pp. 2362-2367
-
-
Kramer, A.1
Postler, G.2
Salhab, K.3
-
6
-
-
0035826096
-
Efficacy and safety of recombinant human activated protein C for severe sepsis
-
Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
-
(2001)
N Engl J Med
, vol.344
, pp. 699-709
-
-
Bernard, G.R.1
Vincent, J.L.2
Laterre, P.F.3
-
7
-
-
0036775076
-
The acute dialysis quality initiative-part VI: Access and antico-agulation in CRRT
-
Davenport A, Mehta S: The acute dialysis quality initiative-part VI: Access and antico-agulation in CRRT. Adv Ren Replace Ther 2002; 4:273-281
-
(2002)
Adv Ren Replace Ther
, vol.4
, pp. 273-281
-
-
Davenport, A.1
Mehta, S.2
-
8
-
-
0001133071
-
Anticoagulation and continuous extracorporal renal replacement therapy
-
Favre H, Martin PY, Stoerman C: Anticoagulation and continuous extracorporal renal replacement therapy. Semin Dial 1996; 9:112-118
-
(1996)
Semin Dial
, vol.9
, pp. 112-118
-
-
Favre, H.1
Martin, P.Y.2
Stoerman, C.3
-
9
-
-
0032703077
-
Hirudin elimination by hemofiltration: A comparative in vitro study of different membranes
-
Rolf DF, Farber H, Stefanidis I: Hirudin elimination by hemofiltration: A comparative in vitro study of different membranes. Kidney Int 2000; 56:S41-S45
-
(2000)
Kidney Int
, vol.56
-
-
Rolf, D.F.1
Farber, H.2
Stefanidis, I.3
-
10
-
-
0034961879
-
Simplified citrate anticoagulation for continuous renal replacement therapy
-
Tolwani A, Campbell RL, Schneck MB: Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001; 60:370-374
-
(2001)
Kidney Int
, vol.60
, pp. 370-374
-
-
Tolwani, A.1
Campbell, R.L.2
Schneck, M.B.3
-
11
-
-
0037350428
-
Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration
-
Kozek-Langenecker SA, Spiss CK, Michalek-Sauberer A, et al: Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Crit Care Med 2003; 31:864-868
-
(2003)
Crit Care Med
, vol.31
, pp. 864-868
-
-
Kozek-Langenecker, S.A.1
Spiss, C.K.2
Michalek-Sauberer, A.3
|